Ovarian function suppression with a GnRH analogue: D-ser(But[t])[6]-Arzgly[10]-LHRH (Goserelin) in hormone dependent canine mammary cancer

Journal of Veterinary Pharmacology and Therapeutics

Volumn 22, Issue 1, 1999, Pages 56-61

  Lombardi, P ^a   Florio, S ^a   Pagnini, U ^a   Crispino, A ^a   Avallone, L ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GONADORELIN DERIVATIVE; GOSERELIN; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; DOG; FEMALE; HORMONE DEPENDENCE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NONHUMAN; OVARY FUNCTION; PRIORITY JOURNAL; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; MAMMARY NEOPLASMS, ANIMAL; NEOPLASMS, HORMONE-DEPENDENT; OVARY; PROGESTERONE;

EID: 0032995896     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1999.00184.x     Document Type: Article

References (40)

1. Bajetta, E., Celio, L., Zilembo, N., Bono, A., Galluzzo, D., Zampino, M.G., Longhi, A., Ferrari, L. & Buzzoni, R. (1994b) Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancer. Tumori, 80, 28-32.
2. Bajetta, E., Zilembo, N., Buzzoni, R., Celio, L., Zampino, M.G., Colleoni, M., Oriana-Attili, A., Sacchini, V. & Martinetti, A. (1994a) Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patients. Oncology, 51, 262-269.
3. Bakker, G.H., Setyono-Han, B., Portengen, H., De Jong, F.H., Foekens, J. & Klijn, J.G.M. (1989) Endocrine and antitumour effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumor. Endocrinology, 125, 1593-1598.
4. Boccardo, P., Rubagotti, A., Perrotta, A., Amoroso, D., Balestrero, M., De Matteis Zola, P., Sismondi, P., Francini, G. & Petrioli, R. (1994) Ovarian ablation versus goserelin with or without tamoxifen in preperimenopausal patients with advanced breast cancer: results of a multicentric Italian study. Annals of Oncology, 5, 337-342.
5. Brogden, R.N. & Faulds, D. (1995) Goserelin: a Review of its Pharmacodynamic and Pharmacokinetic Proprieties and Therapeutic Efficacy in Prostate Cancer. Drugs and Aging, 6, 324-343.
6. Cain, J.L., Cain, G.R., Feldman, E.C., Lasley, B.L. & Stabenfeldt, G.H. (1988) Use of pulsatile intravenous administration of gonadotropin-releasing hormone to induce fertile estrus in bitches. American Journal of Veterinary Research, 49, 1993-1996.
7. Cedars, M.I., Steingold, K.A., de Ziegler, D., Lapolt, P.L., Chong, R.J. & Judd, H.L. (1992) Long term administration of gonadotropin-releasing hormone agonist and dexamethasone: assesment of the adrenal role in ovarian dysfunction. Fertility and Sterility, 57, 495-500.
8. Concannon, P., Lasley, B. & Vanderslip, S. (1997) LH release, induction of oestrus and fertile ovulations in response to pulsatile administration of GnRH to anoestrus dogs. Journal of Reproduction and Fertility, (Suppl.) 51, 41-54.
9. Donnay, I. (1993) Hormono-dependance des tumeurs mammaries de la chienne-Etude epidemiologique et variation des recepteurs a oestrogenes, progesterone et epidermal growth factor dans les tissus mammaries normaux et pathologiques. PhD Thesis, University of Liege, Belgium.
10. Donnay, I., Develeeschouwer, M, Wouters-Ballman, P., Leclerq, G. & Verstegen, J. (1996) Relationship between receptors for epidermal growth factor and steroid hormones in normal, dysplastic and neoplastic canine mammary tissues. Research in Veterinary Science, 60, 251-254.
11. Donnay, I., Rauis, J., Develeeschouwer, N., Wouters-Ballman, P., Leclerq, G. & Verstegen, J. (1995) Changes in concentration and affinities of oestrogen, progesterone and epidermal growth factor receptor during the oestrus cycle in the normal canine mammary gland uterus. Veterinary Research Communications, 19, 101-113.
12. EORTC (European Organization for Research and Treatment Cancer) (1980) Breast Cancer Cooperative Group: revision of the standards for the assessment of hormone receptors in human breast cancer. European Journal of Cancer, 16, 1513-1516.
13. Evans, J.M. (1978) Oestrus control in the bitch. Proceedings of the University of Sydney Post Graduate Committee in Veterinary Science Refresher Course in Canine Medicine, 37, 35-52.
14. Formento, J.L., Francoual, M., Pormento, P., Etienne, M., Fischel, J.L., Namer, M., Frenay, M., Francois, E. & Milano, G. (1990) Epidermal growth factor receptor assay: validation of a single point method and application to breast cancer. Breast Cancer Research and Treatment, 17, 211-219.
15. Grimaux, M., Romain, S., Remvikos, Y., Martin, P.M. & Magdelenat, H. (1989) Prognosis value of epidermal growth factor receptor in node positive breast cancer. Breast Cancer Research and Treatment, 14, 77-90.
16. Kawakami, E., Tonsho, H., Tsutsui, T. & Ogasa, A. (1991) Effects of LHRH-analogue treatment of spermatogenic dysfunction in the dog. International Journal of Andrology, 14, 441-452.
17. Koenders, P.G. (1992) Epidermal growth factor receptor and its ligand(s): associations with prognonsis of patients with breast cancer. PhD Thesis, University of Nijmegen, The Netherlands.
18. Koenders, P.G., Beex, L.V.M. & Benraad, T.J. (1991) Epidermal growth factor receptor-negative tumours are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Research, 51, 4544-4548.
19. Lespagnard, L., Kiss, R., Danguy, A., Legros, N., Lenglet, G., Devleeschouwer, N. & Paridaens, R. (1987) In vitro Studies of Canine Mammary Tumors: Influence of 17-Beta-Estradiol and Progesterone on Cell Kinetics Parameters. Oncology, 44, 292-301.
20. Lowry, O.H., Rosembrough, N.J., Farr, A.L. & Randall, R.J. (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
21. McRae, G.I., Roberts, B.B., Worden, A.C., Bajka, A. & Vickery, B.H. (1985) Long-term reversible suppression of oestrus in bitches with narfarelin acetate, a potent LHRH agonist. Journal of Reproduction and Fertility, 74, 389-397.
22. Mettler, L., Steinmuller, H. & Schachner-Wunschman, E. (1991) Experience with a depot GN RH-agonist (zoladex) in the treatment of genital endometriosis. Human Reproduction, 6, 694-698.
23. Montagnani Marelli, M., Moretti, R.M., Dondi, D., Limonta, P. & Motta, M. (1997) Effects of LHRH agonists on the growth of human prostatic tumour cells: 'in vitro' and 'in vivo' studies. Archivi Italiani Di Urologia E Andrologia, 69, 257-263.
24. Morris, J.S., Dobson, J.M., Bostock, D.E. & O'Farrel, E. (1998) Effect of ovariohysterectomy in bitches with mammary neoplasms. Veterinary Record, 142, 656-658.
25. Moulton, J.E. (1990) Tumours of mammary gland. In Tumours in Domestic Animals. Ed. Moulton, J. E. pp. 518-522. University of California Press, Berkeley.
26. Nicholson, R.I., McClelland, R.A., Gee, J.M., Manning, D.L., Cannon, P., Robertson, J.F., Ellis, I.O. & Blamey, R.W. (1994a) Transforming growth factor-alpha and endocrine sensitivity in breast cancer. Cancer Research, 54, 1684-1689.
27. Nicholson, R.I., McClelland, R.A., Gee, J.M., Manning, D.L., Cannon, P., Robertson, J.F., Ellis, I.O. & Blamey, R.W. (1994b) Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. Breast Cancer Research and Treatment, 29, 117-125.
28. Owen, L.N. (1979) A comparative study of canine and human breast cancer. Investigation in Cell Pathology, 2, 257-275.
29. Owen, L.N. (1980) TNM classification of tumours in domestic animals. In Clinical Veterinary Oncology. Ed. Withrow, S. J. & Macewen, E. G. pp. 457-459. J B Lippincott, Philadelphia.
30. Peeling, W.B. (1989) Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethystilbestrol in treatment of prostatic carcinoma. Urology, 33, 45-53.
31. Perry, C.M. & Brogden, R.N. (1996) Goserelin: a Review of its Pharmacodynamic and Pharmacokinetic Proprieties and Therapeutic Efficacy in Gynaecological Disorders. Drugs, 51, 319-346.
32. Robustelli della Cuna, G. (1992) Principi di endocrinoterapia antitumorale. In Manuale Di Oncologiamedica. Eds. Bonadonna G. & Robustelli della Cuna G. pp. 311-333. Masson, Milan.
33. Sartin, E.A., Rahe, C.H., Wright J.C. & Sartin, J.L. (1995) Luteneinizing Hormone Releasing Hormone, Estrogen, and Progesterone Receptors in Canine Mammary lesions and Tumor Cell Lines. Anticancer Research, 15, 2029-2032.
34. Scatchard, G. (1949) The attraction of proteins for small molecules and ions. Annals of the New York Academy of Sciences, 51, 660-672.
35. Schneider, R. (1970) Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer, 26, 419-426.
36. Schneider, R., Dorn, C.R. & Taylor, D.O. (1969) Factors influencing canine mammary cancer development and postsurgical survival. Journal of National Cancer Institute, 43, 1249-1261.
37. Tyrrel, C.J., Altwein, J.E., Kliffel, F., Varenhorst, E., Boccard, F., Holdaway, I.M., Haefliger, J.M. & Jordan, J.P. (1991) A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. International Prostate Cancer Study Group. Journal of Urology, 146, 1321-1326.
38. Vickery, B.H., McRae, G.I. & Bonasch, H. (1982) Effect of chronic administration of a highly potent LHRH agonist on prostate size and secretory function in geriatric dogs. Prostate, 3, 123-130.
39. Vickery, B.H., McRae, G.I., Goodpasture, J.C. & Sanders, L.M. (1989) Use of a potent LHRH analogues for chronic contraception and pregnancy termination in dogs. Journal of Reproduction and Fertility, (Suppl.) 39, 175-187.
40. Yamagami, T., Kobayashi, T., Takahashi, K. & Sugiyama, M. (1996) Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours. Journal of Small Animal Practice, 37, 462-464.